NCT05849051

Brief Summary

The goal of this research is to assess whether little Cigars and cigarillos (LCC) warnings developed by the study team are more effective than the current warnings proposed by FDA for LCC products. A 3-week web-based randomized controlled trial will be conducted in the United States. Participants are adult persons who currently use LCCs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,029

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 26, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 8, 2023

Completed
14 days until next milestone

Study Start

First participant enrolled

May 22, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 27, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 27, 2023

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

January 8, 2025

Completed
Last Updated

January 8, 2025

Status Verified

January 1, 2025

Enrollment Period

3 months

First QC Date

April 26, 2023

Results QC Date

December 10, 2024

Last Update Submit

January 2, 2025

Conditions

Keywords

Cigar WarningsLittle Cigar UseCigar UseCigarillo Use

Outcome Measures

Primary Outcomes (1)

  • LCC Quit Intentions

    Average quit intention score measured by survey. Quit intention measured with 3 questions, the final quit intention score is a mean of the response to the 3 questions, on a scale of 1 to 4, where 1 indicates low intention to quit, and 4 indicates a high intention to quit.

    day 21 (post test)

Secondary Outcomes (39)

  • Number of LCCs Smoked in Past Day

    day 1

  • Number of LCCs Smoked in Past Day

    day 2

  • Number of LCCs Smoked in Past Day

    day 3

  • Number of LCCs Smoked in Past Day

    day 4

  • Number of LCCs Smoked in Past Day

    day 5

  • +34 more secondary outcomes

Study Arms (3)

Newly developed warnings with images

EXPERIMENTAL

Participants receive newly developed warnings intervention

Behavioral: Newly developed warnings with images at 30% size

FDA proposed text-only warnings

EXPERIMENTAL

Participants receive FDA proposed text only warning intervention

Behavioral: FDA proposed text-only warnings at 30% size

Control group, no intervention

NO INTERVENTION

Participants do not receive an intervention

Interventions

On study days 1-6, 8-13 and 15-20, participants in this condition will view an image of a little cigar and cigarillo package with a warning developed by the study team that includes an image. The warnings will take up 30% of the package. Participants will view a total of 6 different warnings over the course of 6 days each week, this will be repeated 3 times during the study, resulting in a total of 18 exposures. Participants will be required to view the warning for at least 5 seconds.

Newly developed warnings with images

On study days 1-6, 8-13 and 15-20, participants in this condition will view an image of a little cigar and cigarillo package with a warning proposed by the FDA which is text only. The warnings will take up 30% of the package. Participants will view a total of 6 different warnings over the course of 6 days each week, this will be repeated 3 times during the study, resulting in a total of 18 exposures. Participants will be required to view the warning for at least 5 seconds.

FDA proposed text-only warnings

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Members of the recruitment panel (the investigators are partnering with a panel provider for recruitment of all participants)
  • Agree to provide their honest answers
  • Current little cigar and/or cigarillo every day or some day users
  • Over 21 years old
  • Currently living in US
  • Feel comfortable taking a survey in English without help
  • Feel comfortable taking an online survey without help
  • Have an email address that they check regularly
  • Have access to the internet at work or home
  • Able to read and respond to surveys delivered to their email
  • Able to complete 2 surveys that take approximately 20 minutes
  • Able to complete a 5 minute survey each day for 20 days
  • Able to verify they are not a bot using CAPTCHA
  • Able to answer a simple, random math question

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, 27599, United States

Location

Related Publications (1)

  • Goldstein AO, Jarman KL, Ranney LM, Cornacchione Ross J, Kowitt SD, Enyioha C, Clark SA, Sheeran P, Thrasher JF, Jenson D, Vielot NA. Little Cigar and Cigarillo Graphic Health Warnings and Quitting Behaviors: A Randomized Clinical Trial. JAMA Netw Open. 2025 Aug 1;8(8):e2526799. doi: 10.1001/jamanetworkopen.2025.26799.

Related Links

MeSH Terms

Conditions

Tobacco Use

Condition Hierarchy (Ancestors)

Behavior

Results Point of Contact

Title
Adam O Goldstein
Organization
UNC Lineberger Comprehensive Cancer Center

Study Officials

  • Adam O Goldstein

    the University of North Carolina (UNC) Department of Family Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 26, 2023

First Posted

May 8, 2023

Study Start

May 22, 2023

Primary Completion

August 27, 2023

Study Completion

August 27, 2023

Last Updated

January 8, 2025

Results First Posted

January 8, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will share

The investigators will make data collection instruments available for public use after data collection and analyses are complete. On request, the investigators will also make data sets available, stripped of individual identifiers, following publication of the study's main findings.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
The supporting documents and data will become available when study results are submitted to ClinicalTrials.gov. Deidentified study data sets will be available, by request, following publication of the study's main findings.
Access Criteria
The investigators will decide whether to share deidentified study data sets on a case by case basis, and will prioritize sharing the data sets with qualified tobacco regulatory science researchers.

Locations